Luminescence-Based Intracellular ATP and Coupled L-Lactate Quantification in Hypoxia-Challenged HeLa Cells

HeLa cells in 96-well white plates (ATP, luminescence) and clear plates (lactate); 6 replicate wells per condition, 3 independent biological replicates. Conditions: normoxia, hypoxia (1% O2, hypoxia chamber/incubator), and hypoxia + 5 mM 2-DG. Cells seeded at 1 x 10^4/well, allowed to attach 24 h, then exposed 24 h to the oxygen condition. ATP measured by lysing cells in situ; lactate measured in conditioned medium and in cell lysate. Standard curves (ATP and lactate) run on every plate. A cell-free medium blank and a no-cell reagent blank included. Randomize well layout to control edge effects.

BSL-2 — HeLa is a human-derived line; handle with universal precautions in a biosafety cabinet. Hypoxia/tri-gas systems use compressed N2/CO2 — ensure room O2 monitoring to prevent asphyxiation and secure cylinders. 2-DG and oligomycin are toxic — handle in a hood with nitrile gloves; oligomycin stock in DMSO requires extra care. Dispose of cells and assay plates as biohazard waste and chemical-containing reagents per institutional guidelines.

Standard curves: serial ATP (e.g., 1 nM-1 µM) and L-lactate (e.g., 0-10 mM) on every plate anchor quantification. Reagent/no-cell blank corrects background luminescence/fluorescence. Medium-only blank corrects medium lactate/phenol-red interference (hence phenol-red-free medium). Vehicle control: matched water/DMSO for 2-DG. Positive controls: oligomycin-treated wells (ATP depletion via OXPHOS block) and 2-DG-treated wells (glycolysis/lactate suppression) confirm assay sensitivity in both directions. Normoxia is the reference biological condition.

Hypoxic cells show elevated medium and intracellular lactate (often 1.5-3x normoxia) with preserved or modestly reduced ATP. Oligomycin controls drop ATP sharply; 2-DG controls reduce both lactate and ATP. Standard curves are linear (R² > 0.99). Luminescence signal should be well above blank (>10x). Typical HeLa intracellular ATP is in the low-mM range per cell volume; medium lactate accumulates to several mM over 24 h. Replicate CV should be <10-15%.

• HeLa cells (ATCC CCL-2), passage <25, mycoplasma-negative
• DMEM (Gibco 11965) + 10% FBS + 1% pen/strep; phenol-red-free DMEM for lactate reads
• CellTiter-Glo 2.0 luminescent ATP assay (Promega G9241) or equivalent luciferase ATP kit
• ATP disodium salt standard (Sigma A2383) for the ATP standard curve
• L-Lactate Assay Kit (e.g., lactate oxidase/peroxidase + Amplex Red, or Sigma MAK064) with L-lactate standard
• 2-deoxy-D-glucose (Sigma D8375), 500 mM stock; oligomycin (Sigma 75351) as a positive control for ATP depletion
• White opaque 96-well plates (ATP) and clear/black plates (lactate)
• Hypoxia chamber or tri-gas incubator (1% O2, 5% CO2, balance N2); BCA protein kit (Pierce 23225)

To measure intracellular ATP concentration by a firefly luciferase luminescence assay and L-lactate by a coupled lactate-oxidase/peroxidase fluorometric (or luminescent) assay in HeLa cells exposed to normoxic versus hypoxic conditions. Together these readouts report the cellular energy charge and glycolytic output, normalized to cell number or protein, and reveal the metabolic reprogramming induced by low oxygen.

1. Seed HeLa at 1 x 10^4 cells/well in white (ATP) and clear (lactate) 96-well plates; attach 24 h at 37 °C/5% CO2.
2. Switch to fresh phenol-red-free medium; place hypoxia plates in a 1% O2 chamber/incubator and normoxia plates in standard incubator for 24 h. Add 5 mM 2-DG to the inhibitor arm at the start of exposure.
3. ATP assay: equilibrate CellTiter-Glo reagent and plate to RT. Add 100 µL reagent to each 100 µL well, shake 2 min, incubate 10 min in the dark, and read luminescence on a plate reader (integration 0.25-1 s/well).
4. Lactate (medium): collect 10 µL conditioned medium per well; dilute as needed into assay buffer; add lactate reaction mix per kit; incubate 30 min at 37 °C protected from light.
5. Lactate (intracellular): lyse a parallel plate, clear by centrifugation (15,000 x g, 5 min), and assay supernatant.
6. Read lactate by fluorescence (Amplex Red, Ex 530/Em 590) or absorbance per kit.
7. Run ATP and lactate standard curves alongside; record cell number/protein from parallel wells for normalization.

Independent variables: oxygen tension (normoxia vs. 1% O2) and glycolytic inhibition (± 2-DG). Dependent variables: intracellular ATP (luminescence-derived nmol/well or µM) and L-lactate (medium and intracellular, mM or nmol/well). Controlled variables: cell number, exposure duration (24 h), medium volume and composition (phenol-red-free), reagent incubation times and temperature, plate type, reader integration time/gain, and normalization basis (cells or protein).

We hypothesize that hypoxic HeLa cells (1% O2, 24 h) will increase lactate production (medium and intracellular) by ≥50% relative to normoxic controls due to HIF-1α-driven glycolytic upregulation, while maintaining or only modestly reducing intracellular ATP via compensatory glycolytic ATP generation. Inhibiting glycolysis with 2-DG during hypoxia will sharply reduce both ATP and lactate.

Subtract blank from all wells. Interpolate ATP and lactate concentrations from their standard curves (4-parameter or linear fit in GraphPad Prism or plate-reader software). Normalize ATP and intracellular lactate to cell count or µg protein per well; medium lactate normalized to cell number to give per-cell production rate. Compute ATP/lactate ratios as an energy-source indicator. Flag and exclude saturated or below-LOD wells. Aggregate technical replicates to a per-condition mean per biological replicate.

1. Low/no luminescence: reagent not equilibrated to RT, or signal decayed — read within the stable window and protect from light; verify luciferase reagent freshness. 2. Nonlinear ATP standard curve: pipetting error or ATP hydrolysis — make fresh ATP standard on ice. 3. High medium-lactate blank: phenol red or FBS interference — use phenol-red-free medium and a medium-only blank. 4. No hypoxia effect: chamber not reaching 1% O2 or cells too sparse for HIF stabilization — verify O2 with a sensor and confirm HIF-1α stabilization by Western if needed. 5. Saturated lactate signal: dilute conditioned medium into the linear range before assay.

Biological replicate (n=3) is the experimental unit. For normoxia vs. hypoxia, paired two-tailed t-test on each readout. For the three-condition design (normoxia, hypoxia, hypoxia+2-DG), one-way ANOVA with Dunnett's post-hoc (vs. normoxia) or Tukey HSD. Set alpha = 0.05; correct across the two readouts (ATP, lactate) with Holm-Bonferroni if treated as a family. Report mean ± SEM and exact p-values; n=3-4 gives ~80% power for the expected ≥50% effect.